BCL11B antibody

Synonyms:B cell CLL/lymphoma 11B antibody, B cell lymphoma/leukemia 11B antibody, BCL11B antibody, COUP TF interacting protein 2 antibody, CTIP 2 antibody, CTIP2 antibody, hRit1 antibody, hRIT1 alpha antibody, RIT1 antibody
Catalogue No.:FNab00838Reactivity:Human, Mouse
Host:RabbitTested Application:ELISA, WB, IP
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
Product Name
BCL11B antibody
Catalogue No.
FNab00838
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
B-cell CLL/lymphoma 11B(zinc finger protein)
Alternative Names
B cell CLL/lymphoma 11B antibody, B cell lymphoma/leukemia 11B antibody, BCL11B antibody, COUP TF interacting protein 2 antibody, CTIP 2 antibody, CTIP2 antibody, hRit1 antibody, hRIT1 alpha antibody, RIT1 antibody
UniProt ID
Q9C0K0
Observed MW
116 kDa
Application
Tested Applications
ELISA, WB, IP
Recommended dilution
WB: 1:200-1:1000; IP: 1:500-1:1000
Validated Images
Jurkat cells were subjected to SDS PAGE followed by western blot with FNab00838(BCL11B antibody) at dilution of 1:500
IP Result of anti-BCL11B (IP:FNab00838, 4ug; Detection:FNab00838 1:500) with Jurkat cells lysate 2800ug.
Background
Tumor-suppressor protein involved in T-cell lymphomas. May function on the P53-signaling pathway. May be a key regulator of both differentiation and survival during thymocyte development. Repress transcription through direct, TFCOUP2-independent binding to a GC-rich response element(By similarity).